Kaya, A.Aras, İ.Kurtgöz, P.Ö.Çakıroğlu, U.2025-05-102025-05-1020241300-777710.4274/tjh.galenos.2023.2023.03682-s2.0-85186958920https://doi.org/10.4274/tjh.galenos.2023.2023.0368https://hdl.handle.net/20.500.14720/3414eninfo:eu-repo/semantics/openAccessChronic Lymphocytic LeukemiaIbrutinibIbrutinib-Associated VasculitisLeukocytoclastic VasculitisIbrutinib-Associated Leukocytoclastic Vasculitis in a Patient With Chronic Lymphocytic LeukemiaLetter411Q3Q3575838433497